Real-time enrollment status for this treatment-resistant depression clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 8:00 AM UTC
| NCT Number | NCT06713616 |
| Recruiting Status | Recruiting |
| Condition | Treatment-Resistant Depression |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Yale University |
| Last Updated on CT.gov | July 31, 2026 (Jul 31, 2026) |
As of September 2, 2026: Clinical trial NCT06713616 is currently recruiting participants. This phase3 study for treatment-resistant depression is actively seeking new participants at 8 locations across the United States. The study is sponsored by Yale University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06713616 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06713616 was last updated Jul 31, 2026 (July 31, 2026). HelloStudys verifies this status automatically.